Publish Date: 08-Aug-2019
Increasing awareness about pregnancy & childbirth, aging & menopause, fertility management, and sexual health worldwide are primary factors driving the demand for PGT. Moreover, an increase in the adoption of IVF procedures can be seen as a result of late marriages, infertility, and growing ambitious population in the developing regions. One in each four couples in the developing countries is affected by infertility. Moreover, PGD benefits the couples suffering from hereditary disorders, which, in turn, is driving demand for preimplantation genetic testing. With increasing infertility in men, some of the start-ups are helping males in solving their erectile-dysfunction predicament by providing appropriate drugs online.
Increasing Initiatives to Promote Healthy Pregnancies
Preimplantation genetic testing, by type, is segmented into the preimplantation genetic screening, preimplantation genetic diagnosis.
PGD segment is accounting for the largest market share during the forecast period. Moreover, increasing government efforts to support healthy pregnancies are progressing the market. For instance, in 2017, the Switzerland government passed a medial law to allow pre-implantation genetic diagnosis. As per Switzerland government, around 500–1,000 couples every year undergo IVF treatment. Moreover, to lessen the burden on families and to promote IVF in developing countries, many banks provide EMI’s for treatment. For instance, in india, Bajaj Finance offer lifecare maternity care and IVF treatment. It is available in 400 cities and in partnership with over 2700 hospitals to cover a wide population.
Product & service segment is divided into reagents & consumables, instruments, and software & services. The reagents & consumables segment is generating the highest revenue following increasing applications of diagnostic technologies.
Asia Pacific to Witness Growth in the Demand for Preimplantation Genetic Testing
Got questions about your regional growth of
Preimplantation Genetic Testing Market ?
Just drop us a line or call on +1 646 480 7505
Currently, Asia Pacific is witnessing significant growth in infertility rate. Late marriages, rising number of singles, preference for no children, and higher divorce rates are major factors affecting the fertility. According to the Indian Society of Assisted Reproduction, infertility affects about 10%-14% of the Indian population. Moreover, in Australia and New Zealand, 1 in 6 couples suffers from infertility, Fertility Society of Australia. Apart from this, the Australian government is providing infertile couples with insurance coverage to promote the benefits of IVFin the region. Japan, Singapore, and South Korea’s total fertility rate have been plummeted to 1.44, 1.20, and 1.17, respectively, the World Bank. Hong Kong has one of the lowest fertility rates in the world, which is adding fuel to the demand for PGT and IVF in this region. In India, data-driven fertility program Elawoman has raised USD 3 million in funding by Chiratae Ventures.
The Middle East and Africa are offering significant growth opportunities in the global preimplantation genetic testing market. Moreover, the outbreak of zika virus in Africa has increased the cases of preterm birth, miscarriages, and microcephaly. In the Middle East, congenital malformations are one of the leading causes of infant mortality, WHO.
Competitive Landscape
Several key players are taking continuous efforts for developing innovative products and expanding market presence.
In 2018, Natera, a prominent leader in non-invasive genetic testing, shared a study on spectrum preimplantation genetic screening, innovative technology to improve IVF outcomes. Spectrum PGT-A is found to reduce the negative risks for IVF by allowing only suitable embryos.
In 2018, Illumina Inc. entered into an agreement with Vitrolife AB. In this, Vitrolife will distribute Illumina’s PGT products in America and EMEA.
Some of the other players active in the market are Illumina, Inc, SciGene Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and Yikon Genomics.
Preimplantation Genetic Testing Market Segmentation
By Procedure Type
By Technology
By Product and Service
By Application
By End User
Regions Covered
America
Europe
Asia-Pacific
MEA
Key Players
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast Periods
View Full Report Buy This Report Now Empty Capsules Market to Reach USD 3,745.5 Million by 2026 at a CAGR 7.4%
Capsules are a preferred dosage form across all the demographic subsets following its ease of handling and swallowing, palatability, and
Viral Vector Manufacturing Market to Grow at a CAGR of 9.2% During 2019–2026
Increasing prevalence of chronic diseases and targeted diseases are driving the demand for gene therapy. During viral vector transmission, it is ensured that the viral particle is not infectious. T
The Dynamic Shift From Traditional Sensors to Smart Sensors Will Drive the Industrial Sensors Market.
The real-time monitoring of machine parameters and equipment designed with predictive maintenance require sensors, which is one of the key factors driving advancements in these devices. IO-Link, a
